Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)

about

Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)

Item

http://www.wikidata.org/entity/Q58772579

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Core-binding factor acute myeloid leukemia with t

@nl

Core-binding factor acute myel ...... novel scoring system (I-CBFit)

@en

type

Item

label

Core-binding factor acute myeloid leukemia with t

@nl

Core-binding factor acute myel ...... novel scoring system (I-CBFit)

@en

prefLabel

Core-binding factor acute myeloid leukemia with t

@nl

Core-binding factor acute myel ...... novel scoring system (I-CBFit)

@en

P1476

Core-binding factor acute myel ...... novel scoring system (I-CBFit)

@en

P2093

Amandeep Salhotra

http://www.w3.org/2001/XMLSchema#string

Ana-Iris Schiefer

http://www.w3.org/2001/XMLSchema#string

Cecilia Arana Yi

http://www.w3.org/2001/XMLSchema#string

Cecilia Yeung

http://www.w3.org/2001/XMLSchema#string

Celalettin Ustun

http://www.w3.org/2001/XMLSchema#string

Cem Akin

http://www.w3.org/2001/XMLSchema#string

Christina Cho

http://www.w3.org/2001/XMLSchema#string

Daniel Weisdorf

http://www.w3.org/2001/XMLSchema#string

David Czuchlewski

http://www.w3.org/2001/XMLSchema#string

Dong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic Opportunities

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.

Acute Myeloid Leukemia

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.

P304

4447-4455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1733

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30117318

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6144246

http://www.w3.org/2001/XMLSchema#string